Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05241353
Other study ID # PROJECTTHRIVE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 25, 2022
Est. completion date February 1, 2023

Study information

Verified date January 2023
Source Drexel University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized pilot trial will compare two approaches to dietary self-monitoring for weight loss in the context of a low-intensity, remotely-delivered lifestyle modification program. Participants (N=40) will be randomized to perform detailed self-monitoring of all food and drink consumed each day or a reduced frequency, partial prescription involving recording only a subset of daily intake. The investigators will compare differences in weight loss as well as on relevant mechanistic, behavioral outcomes between groups at 12 weeks.


Description:

Most lifestyle modification programs for weight loss require comprehensive, precise dietary self-monitoring (DSM) of all food and drink consumed each day. Although theoretically, such approaches should maximize the ability to identify dietary modifications leading to weight loss, the high level of burden associated with these requirements may produce suboptimal weight loss outcomes for many individuals by compromising DSM compliance, accuracy, and utilization for behavior change. A few prior trials have attempted to address this concern by relaxing the standard DSM requirement to record caloric intake precisely. However, such approaches are likely limited in efficacy because they reduce the utility DSM for implementing specific dietary changes. An alternative, as-of-yet untested approach to lower DSM burden would be to require that DSM be performed precisely but with reduced frequency, i.e., only during eating occasions strongly associated with eating patterns that threaten weight control. Thus, the purpose of the current pilot trial will be to compare the standard DSM protocol to a novel, reduced-frequency DSM approach in the context of a 12-week, low-intensity weight loss intervention. Participants (N = 40) will be randomized to receive either standard DSM advice or a reduced-frequency prescription and will receive four remotely-delivered individual coaching calls. The primary aim will be to investigate whether relative to standard DSM, reduced-frequency DSM can yield superior outcomes on four prospective indicators of long-term weight loss success (attitudes, DSM accuracy, utilization of DSM, and sustained compliance with DSM) and also produce comparable weight outcomes by 12 weeks. All participants will receive a 12-week, low-intensity coaching-based intervention consisting of four individual coaching contacts. All study contacts will occur remotely using the HIPAA-compliant Zoom service at Drexel University. Participants will first complete preliminary eligibility screening via telephone and eligibility will be confirmed during an individual baseline assessment, during which participants will also receive an overview of study procedures. Following the baseline assessment but prior to the first coaching call, participants will engage in fully comprehensive, standard DSM for one week to generate data on the participant's typical dietary patterns, and these data will be used to tailor the DSM prescription in the reduced-frequency DSM group. Participants will also be provided with weekly electronic reading material on principles of behavioral weight control. The first coaching call will be one hour in duration and will provide an overview of general behavioral principles of weight control, including requiring the participant to set specific calorie reduction, self-monitoring and physical activity goals. Participants will also be randomized at during the first coaching call one-to-one fashion to either receive standard DSM advice or to receive a reduced frequency prescription that requires recording only a subset of eating each day throughout the intervention. Permuted block randomization will be performed, stratified on baseline BMI (groups: BMI <30, BMI 30-35, BMI >35). Depending on the participant's assignment, he/she/they will be assigned during the baseline coaching call to either continue recording all dietary intake each day (using the Fitbit mobile application) or record a subset of eating tailored to the individual's within-day dietary patterns using a simple algorithm. Subsequent coaching calls will focus on a review of adherence to dietary and physical activity goals and problem-solving solutions to the participant's stated barriers to adherence. Participants in the reduced-frequency group will also have opportunities to modify the self-monitoring prescription during subsequent coaching calls depending on the perceived feasibility of their current prescription. Lastly, participants in both groups will complete a post-treatment assessment during which self-report measures will be completed and skills to maintain after treatment will be reviewed.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date February 1, 2023
Est. primary completion date February 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Age 18-75 years old - Currently living in the United States - Current body mass index (BMI) of 25-50 kg/m2, with individuals with BMI > 50 excluded due to the higher risk of medical complications - Access to a regular internet connection - Ability to understand and provide informed consent - Individuals must provide consent for the research team to contact their personal physician if necessary, to provide clearance or to consult about rapid weight loss - Proficiency in speaking, reading, and writing English - Ability to engage in physical activity, defined as the ability to walk at least the length of two city blocks without stopping - Access to or willing to purchase a digital wireless body weight scale Exclusion Criteria: - Present involvement in another lifestyle modification or obesity treatment program - Currently breastfeeding, pregnant or planning to become pregnant within 4 months from the time of screening - Having lost more than 5% of body weight in the past 3 months - History of bariatric surgery - Acute suicide risk (exclude if present in the past 2 weeks or if any attempts were made in past 2 years) - Self-reported diagnosis of a medical or psychiatric condition that could make standard behavioral weight loss treatment contraindicated, including: insulin-dependent diabetes (type 1 or type 2; individuals with diabetes who do not take insulin will not be excluded), cancer, loss-of-control eating (three or more times in the past month), inappropriate compensatory behaviors to control weight (vomiting, misuse of laxatives or diuretics, or compelled exercise) in the past month, current unmedicated bipolar or psychotic disorder, or current psychiatric symptoms that would interfere with an individual's ability to complete the program. - Technological or interpersonal difficulties contraindicating participation in a remotely delivered coaching program

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Reduced Frequency Self-Monitoring
Participants will be asked to record only a subset of daily eating throughout the intervention, with the prescription for self-monitoring individually tailored at baseline dependent on participants' self-reported eating patterns.
Full-Frequency Self-Monitoring
Participants will be asked to record all contents of their diet throughout the intervention.
Standard Behavioral Treatment
Participants will receive four individual coaching calls over 12 weeks. During coaching calls, participants will receive guidance on lowering calorie intake, increasing physical activity and use of specific behavioral strategies to increase the probability of success with weight loss.

Locations

Country Name City State
United States Drexel University Center for Weight, Eating & Lifestyle Science Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Drexel University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Baseline Percent Weight Loss at Week 12 Weight will be assessed at baseline and weekly throughout the intervention. Participants will be instructed to self-weigh on one consistent morning per week before 11am, following specific instructions (i.e., wear light clothing, keep scale on a flat surface, weigh before eating or drinking) and then self-report weight using the Fitbit app where it can be later exported by research staff. Participants will be required to self-weigh using a reliable, digital wireless scale that can estimate weight to the nearest tenth of a pound. Percent weight loss at week 12 will be calculated as the percentage loss in initial body weight at baseline by the time of the post-treatment assessment. Week 0 (Baseline), Week 12 (Post-Treatment)
Secondary Perceived Autonomy Support at Week 12 Perceived autonomy support will be evaluated using a modified version of the Health Care Climate Questionnaire, which has strong psychometric properties (a = 0.97). This 15-item measure examines the extent to which an individual feels supported by their health care provider to take personal responsibility for his or her health. Scores are calculated as the mean of all items on the scale, reverse-scoring item 13. Scores on the scale range from 1 to 7, with higher scores indicating higher perceived autonomy support. Perceived autonomy support will be assessed only at post-treatment. Week 12 (Post-Treatment)
Secondary Change in Weekly Compliance with DSM from Weeks 1 to 12 Compliance with dietary self-monitoring (DSM) will be operationalized as the proportion of required meals and snacks recorded (based on the participant's eating plan) each week. Recording of a given meal or snack will be defined as the presence of at least one food item logged for a snack and two food items logged for a meal. To calculate the proportion of required meals and snacks recorded each day, the total number of recorded meals and snacks will be divided by a constant representing the "expected" number of eating occasions (two for the reduced frequency DSM group; for the standard DSM group, this value will correspond to the number of eating occasions in the participant's eating plan). This proportion will initially be computed at the day level and will then be averaged across each week during the intervention phase for each participant. Change in compliance with DSM will be evaluated weekly over the course of the 12-week intervention (i.e., weeks 1-12). Week 1 through Week 12 (Post-Treatment)
Secondary Change in Week 3 Utilization of Strategies to Ensure DSM Accuracy at Week 12 This variable will be assessed via self-report at week 3 and at post-treatment (Week 12). Participants will be asked to rate on a five-item Likert scale the extent to which 10 statements describing efforts to perform highly precise DSM (e.g., "I always tracked hidden calories like oils, cream, butter, and added sugars," "I always weighed or measured my food before entering it into my food record") have applied to them over the past three weeks (1 = Never, 5 = Always). A composite score will be computed as the mean score of all items on the scale. Change in this variable will be assessed as a difference score between week 3 and post-treatment. Week 3, Week 12 (Post-Treatment)
Secondary Change in Week 3 Utilization of DSM for Dietary Change at Week 12 Utilization of DSM will first be assessed at week 3, to ensure that participants have first had an opportunity to fully engage in DSM for several weeks, and then again at post-treatment. This measure will ask participants to rate the extent to which they utilized self-monitoring records to make specific dietary changes over the past three weeks. Participants will be presented with a list of 15 potential dietary modifications related to weight control (e.g., decreased intake of calories from beverages, increased consumption of fruits/vegetables) and asked to endorse which, if any, they have made related to their personal DSM practice during the intervention. A total score for utilization of DSM will be computed as the total number of items on the list endorsed. Change in this variable will be assessed as a difference score between week 3 and post-treatment (week 12). Week 3, Week 12 (Post-Treatment)
Secondary Change in Baseline Attitudes Towards DSM at Week 12 Attitudes towards DSM will be assessed at baseline (Week 0) and post-treatment (Week 12) using four, five-point custom Likert scale items. Items will assess participant perceptions of usefulness ("I think that tracking my calories is useful for losing weight"), liking ("I like tracking what I eat using the Fitbit app"), burden associated with DSM ("Tracking my calories feels like too much work to be worth it") and intention to continue engaging in DSM over the upcoming year (1 = not at all confident, 5 = extremely confident). A composite index of attitudes towards DSM will be computed from the average of the perceived usefulness, liking, burden, and intention to maintain items, reverse-scoring the burden item. Change in attitudes towards DSM will be assessed as a difference score between baseline and post-treatment. Week 0 (Baseline), Week 12 (Post-Treatment)
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2